Rosuvastatin adherence app study in China

Trial Identifier: D3560C00088
Sponsor: AstraZeneca
NCTID:: NCT02433288
Start Date: July 2015
Primary Completion Date: October 2016
Study Completion Date: October 2016
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China beijing, China, 100191
China Beijing, China, 100049
China Beijing, China, 100044
China Beijing, China, 100700
China Beijing, China, 100037
China Beijing, China, 100730
China Beijing, China, 101199
China Beijing, China, 100038
China Beijing, China, 100029
China Beijing, China, 100034
China Beijing, China, 100045
China changsha, China, 410005
China Changsha, China, 410013
China Changsha, China, 410011
China Chengdu, China, 610041
China Chongqing, China, 400013
China Dongying, China, 257091
China Hang Zhou, China, 310003
China Heilongjiang, China, 150086
China Huzhou, China, 313003
China Jinan, China, 250021
China Nanchang, China, 330009
China Nanjing, China, 2100008
China Qingdao, China, 266011
China Qingdao, China, 266300
China Shandong, China, 262700
China Shanghai, China, 200031
China Shanghai, China, 200050
China Shanghai, China, 200240
China Shanghai, China, 201199
China Shanghai, China, 200072
China Tianjin, China, 300192
China Tianjin, China, 300211
China Tianjin, China, 300000
China Tianjin, China, 300051
China Tianjin, China, 300142
China Waifang, China, 261500
China Wenzhou, China, 325000
China wuhan, China, 430022
China Xi'an, China, 710061